The World Kabaddi League (WKL) on Tuesday announced that 23 players have reported for anti-doping rule violation in both in and out of competition tests.
Out of the 20 names made public by the WKL, only two — Randeep Kumar and Amandeep Singh Gill — were tested in-competition on August 23 and Sept. 9 respectively.
Six of them were tested out-of-competition during the event between Aug. 5 and Sept. 20.
The rest were tested at Ludhiana prior to the commencement of the league on June 14 and 15.
Interestingly, all the 20 athletes have tested positive for steroids.
According to the WKL, Navneet Singh and Amandeep Singh Gill have used an assortment of four banned drugs (Norandrosterone, Boldenone, Noreticholanolone and Stanozolol), while Kuldeep Singh (Norandrosterone, Noreticholanolone and Trenbolone) and Baljinder Singh (Norandrosterone, Noreticholanolone and Stanozolo) have used a combination of three prohibited substances.
Norandrosterone and Noreticholanolone are the most popular drugs as 11 of them have used these two.
Names of three other players, including two from in-competition tests, have not been declared intentionally as their cases were under notice period, said a WKL release.
The WKL CEO, Raman Raheja, said these athletes were given the opportunity to appear before the Anti-Doping Disciplinary Board, but many of them did not do so within the stipulated time period of 15 days.
Details shared with WADA
He said the details had been shared with the WADA and WKL would impose necessary sanctions on these athletes.
The WKL claimed that altogether 464 tests had been done by a Bangkok-based World Anti-Doping Agency (WADA)-accredited agency.
